BTSG SEC filings (2026)
CIK 1865782 · Services-Home Health Care Services (SIC 8082) · incorporated in DE · fiscal year ends in December
238 filings on EDGAR since 2021 · 3 annual, 9 quarterly, 35 current · financial statements · earnings
What happened, last 12 months#
Every earnings release with its print, every report with its quarter, the other 8-Ks by the headline of the press release they furnish or by their items, the proxy statements, and each day an insider bought or sold — newest first, each line opening the filing on EDGAR. The index by form and year follows.
October 2026
September 2026
July 2026
June 2026
- Jun 128-K8-K · BrightSpring Health Services, Inc. Welcomes Dr. Nigam H. Shah to Board of DirectorsDirectors or officers; compensation; Regulation FD disclosure
- Jun 5Insider saleKKR Phoenix Aggregator L.P., KKR Phoenix Aggregator GP LLC, KKR Americas Fund XII L.P., KKR Associates Americas XII L.P., KKR Americas XII Ltd (5 filers) sold 14,669,771 shares for $857.5M at $58.45
- Jun 5Insider saleKKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, KRAVIS HENRY R, ROBERTS GEORGE R (7 filers) sold 14,669,771 shares for $857.5M at $58.45
- Jun 5Insider saleROUSSEAU JON B (See Remarks · Director) sold 260,000 shares for $15.3M at $58.75
- Jun 5Insider salePhipps Jennifer A (Chief Financial Officer) sold 35,000 shares for $2.1M at $58.75
- Jun 5Insider saleNalley Lisa A (See Remarks) sold 35,000 shares for $2.1M at $58.75
- Jun 58-K8-K · Material definitive agreement
May 2026
April 2026
- Apr 10ProxyProxy · Annual report to shareholders
- Apr 10ProxyProxy · Additional proxy materials
- Apr 10ProxyProxy · Proxy statement
March 2026
- Mar 318-K8-K · BrightSpring Health Services Completes Sale of ResCare Community Living to SevitaCompletion of an acquisition or disposition; Directors or officers; compensation; Regulation FD disclosure
- Mar 4Insider saleKKR Phoenix Aggregator L.P., KKR Phoenix Aggregator GP LLC, KKR Americas Fund XII L.P., KKR Associates Americas XII L.P., KKR Americas XII Ltd (5 filers) sold 19,715,000 shares for $807.5M at $40.96
- Mar 4Insider saleKKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, KRAVIS HENRY R, ROBERTS GEORGE R (7 filers) sold 19,715,000 shares for $807.5M at $40.96
- Mar 4Insider saleROUSSEAU JON B (See Remarks · Director) sold 220,000 shares for $9.1M at $41.15
- Mar 4Insider salePhipps Jennifer A (Chief Financial Officer) sold 35,000 shares for $1.4M at $41.15
- Mar 4Insider saleNalley Lisa A (See Remarks) sold 30,000 shares for $1.2M at $41.15
- Mar 48-K8-K · Material definitive agreement
February 2026
Insider transactions#
What officers, directors and 10% holders reported on Forms 4 and 5 over the last 13 months, from the documents themselves: one insider’s trades of one kind on one day are one row, with the shares, the price range and the total as filed. Open-market buys and sells first; awards, exercises, tax withholding, gifts and employee-plan purchases are grouped below them.
Over the last 13 months insiders sold $3.36B in 11 sales and bought nothing on the open market; 48 other transactions (awards, exercises, tax withholding, gifts and plan purchases).
| Date | Insider |
|---|---|
| Sep 14, 2026Form 4 | Greenwell Scott A.President, PharMericaSold · $874K · 15,099 sh · 10b5-1 |
| Jun 5, 2026Form 4 | KKR Phoenix Aggregator L.P., KKR Phoenix Aggregator GP LLC, KKR Americas Fund XII L.P., KKR Associates Americas XII L.P., KKR Americas XII Ltd5 filersSold · $857.5M · 14,669,771 sh |
| Jun 5, 2026Form 4 | KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, KRAVIS HENRY R, ROBERTS GEORGE R7 filersSold · $857.5M · 14,669,771 sh |
| Jun 5, 2026Form 4 | ROUSSEAU JON BSee Remarks · DirectorSold · $15.3M · 260,000 sh |
| Jun 5, 2026Form 4 | Phipps Jennifer AChief Financial OfficerSold · $2.1M · 35,000 sh |
| Jun 5, 2026Form 4 | Nalley Lisa ASee RemarksSold · $2.1M · 35,000 sh |
| Mar 4, 2026Form 4 | KKR Phoenix Aggregator L.P., KKR Phoenix Aggregator GP LLC, KKR Americas Fund XII L.P., KKR Associates Americas XII L.P., KKR Americas XII Ltd5 filersSold · $807.5M · 19,715,000 sh |
| Mar 4, 2026Form 4 | KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, KRAVIS HENRY R, ROBERTS GEORGE R7 filersSold · $807.5M · 19,715,000 sh |
| Mar 4, 2026Form 4 | ROUSSEAU JON BSee Remarks · DirectorSold · $9.1M · 220,000 sh |
| Mar 4, 2026Form 4 | Phipps Jennifer AChief Financial OfficerSold · $1.4M · 35,000 sh |
| Mar 4, 2026Form 4 | Nalley Lisa ASee RemarksSold · $1.2M · 30,000 sh |
Awards, exercises, withholding and plan purchases · 48 transactions
| Date | Insider |
|---|---|
| Oct 25, 2026Form 4 | ROUSSEAU JON BSee Remarks · DirectorTax withholding · $2.2M · 36,355 sh |
| Sep 14, 2026Form 4 | Greenwell Scott A.President, PharMericaExercise or conversion · $267K · 11,973 sh · 10b5-1 |
| Sep 14, 2026Form 4 | Greenwell Scott A.President, PharMericaExercise or conversion · Stock Options (Right to Buy) · $0 · 11,973 sh · 10b5-1 |
| Jul 25, 2026Form 4 | ROUSSEAU JON BSee Remarks · DirectorTax withholding · $4.1M · 56,319 sh |
| Jun 20, 2026Form 4 | Greenwell Scott A.President, PharMericaTax withholding · $165K · 2,487 sh |
| Jun 11, 2026Form 4 | Shah Nigam H.DirectorAward · $0 · 4,013 sh |
| Jun 5, 2026Form 4 | ROUSSEAU JON BSee Remarks · DirectorExercise or conversion · $1.7M · 260,000 sh |
| Jun 5, 2026Form 4 | Phipps Jennifer AChief Financial OfficerExercise or conversion · $223K · 35,000 sh |
| Jun 5, 2026Form 4 | Nalley Lisa ASee RemarksExercise or conversion · $223K · 35,000 sh |
| Jun 5, 2026Form 4 | KKR Phoenix Aggregator L.P., KKR Phoenix Aggregator GP LLC, KKR Americas Fund XII L.P., KKR Associates Americas XII L.P., KKR Americas XII Ltd5 filersOther · $0 · 324,608 sh |
| Jun 5, 2026Form 4 | KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, KRAVIS HENRY R, ROBERTS GEORGE R7 filersOther · $0 · 324,608 sh |
| Jun 5, 2026Form 4 | ROUSSEAU JON BSee Remarks · DirectorExercise or conversion · Stock Options (Right to Buy) · $0 · 260,000 sh |
| Jun 5, 2026Form 4 | KKR Phoenix Aggregator L.P., KKR Phoenix Aggregator GP LLC, KKR Americas Fund XII L.P., KKR Associates Americas XII L.P., KKR Americas XII Ltd5 filersGift · $0 · 60,190 sh |
| Jun 5, 2026Form 4 | KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, KRAVIS HENRY R, ROBERTS GEORGE R7 filersGift · $0 · 60,190 sh |
| Jun 5, 2026Form 4 | Phipps Jennifer AChief Financial OfficerExercise or conversion · Stock Options (Right to Buy) · $0 · 35,000 sh |
| Jun 5, 2026Form 4 | Nalley Lisa ASee RemarksExercise or conversion · Stock Options (Right to Buy) · $0 · 35,000 sh |
| May 5, 2026Form 4 | Wicks Timothy ADirectorAward · $0 · 4,983 sh |
| May 5, 2026Form 4 | KIRTLEY OLIVIA FDirectorAward · $0 · 4,983 sh |
| May 5, 2026Form 4 | Miller Steven BDirectorAward · $0 · 4,983 sh |
| Apr 25, 2026Form 4 | ROUSSEAU JON BSee Remarks · DirectorTax withholding · $781K · 16,222 sh |
| Mar 30, 2026Form 4 | Barnes Robert AllenPresident, Community LivingTax withholding · $280K · 6,748 sh |
| Mar 20, 2026Form 4 | ROUSSEAU JON BSee Remarks · DirectorGift · Stock Options (Right to Buy) · $0 · 1,132,322 sh |
| Mar 5, 2026Form 4 | ROUSSEAU JON BSee Remarks · DirectorAward · Stock Options (Right to Buy) · $0 · 458,008 sh |
| Mar 5, 2026Form 4 | ROUSSEAU JON BSee Remarks · DirectorAward · $0 · 186,845 sh |
| Mar 5, 2026Form 4 | Phipps Jennifer AChief Financial OfficerAward · Stock Options (Right to Buy) · $0 · 130,860 sh |
| Mar 5, 2026Form 4 | Phipps Jennifer AChief Financial OfficerAward · $0 · 53,384 sh |
| Mar 5, 2026Form 4 | Nalley Lisa ASee RemarksAward · Stock Options (Right to Buy) · $0 · 52,344 sh |
| Mar 5, 2026Form 4 | Greenwell Scott A.President, PharMericaAward · Stock Options (Right to Buy) · $0 · 49,073 sh |
| Mar 5, 2026Form 4 | Nalley Lisa ASee RemarksAward · $0 · 21,354 sh |
| Mar 5, 2026Form 4 | Greenwell Scott A.President, PharMericaAward · $0 · 20,020 sh |
| Mar 4, 2026Form 4 | ROUSSEAU JON BSee Remarks · DirectorExercise or conversion · $1.4M · 220,000 sh |
| Mar 4, 2026Form 4 | Phipps Jennifer AChief Financial OfficerExercise or conversion · $223K · 35,000 sh |
| Mar 4, 2026Form 4 | Nalley Lisa ASee RemarksExercise or conversion · $191K · 30,000 sh |
| Mar 4, 2026Form 4 | ROUSSEAU JON BSee Remarks · DirectorAward · Stock Options (Right to Buy) · $0 · 955,823 sh |
| Mar 4, 2026Form 4 | KKR Phoenix Aggregator L.P., KKR Phoenix Aggregator GP LLC, KKR Americas Fund XII L.P., KKR Associates Americas XII L.P., KKR Americas XII Ltd5 filersOther · $0 · 402,773 sh |
| Mar 4, 2026Form 4 | KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, KRAVIS HENRY R, ROBERTS GEORGE R7 filersOther · $0 · 402,773 sh |
| Mar 4, 2026Form 4 | ROUSSEAU JON BSee Remarks · DirectorExercise or conversion · Stock Options (Right to Buy) · $0 · 220,000 sh |
| Mar 4, 2026Form 4 | KKR Phoenix Aggregator L.P., KKR Phoenix Aggregator GP LLC, KKR Americas Fund XII L.P., KKR Associates Americas XII L.P., KKR Americas XII Ltd5 filersGift · $0 · 81,213 sh |
| Mar 4, 2026Form 4 | KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, KRAVIS HENRY R, ROBERTS GEORGE R7 filersGift · $0 · 81,213 sh |
| Mar 4, 2026Form 4 | Phipps Jennifer AChief Financial OfficerAward · Stock Options (Right to Buy) · $0 · 41,219 sh |
| Mar 4, 2026Form 4 | Nalley Lisa ASee RemarksAward · Stock Options (Right to Buy) · $0 · 39,256 sh |
| Mar 4, 2026Form 4 | Phipps Jennifer AChief Financial OfficerExercise or conversion · Stock Options (Right to Buy) · $0 · 35,000 sh |
| Mar 4, 2026Form 4 | Nalley Lisa ASee RemarksExercise or conversion · Stock Options (Right to Buy) · $0 · 30,000 sh |
| Mar 3, 2026Form 4 | Barnes Robert AllenPresident, Community LivingAward · Stock Options (Right to Buy) · $0 · 38,275 sh |
| Jan 25, 2026Form 4 | ROUSSEAU JON BSee Remarks · DirectorTax withholding · $2.0M · 49,304 sh |
| Jan 25, 2026Form 4 | Phipps Jennifer AChief Financial OfficerTax withholding · $1.3M · 33,190 sh |
| Jan 25, 2026Form 4 | Nalley Lisa ASee RemarksTax withholding · $815K · 20,556 sh |
| Jan 25, 2026Form 4 | Barnes Robert AllenPresident, Community LivingTax withholding · $276K · 6,972 sh |
Reports and proxy statements#
Annual reports (10-K, 20-F, 40-F), quarterly reports (10-Q), current reports (8-K, 6-K) and proxy statements, newest first. An 8-K that furnishes a press release is headed by the release’s headline, its items beneath; any other 8-K is described by its items. A form opens the press release where there is one, else the document on EDGAR, or the filing’s index where it furnishes other exhibits.
2026 · 16 filings
| Filed | What it is |
|---|---|
| Oct 30, 202610-Q | Quarterly report, Q3 2026 — revenue $4.21B (+26% y/y), net income $100.1M, EPS $0.45 |
| Oct 30, 20268-K | Earnings release — EPS $0.54 vs $0.45 est. (+20.0%); revenue $4.21B (+26% y/y) 11.1% |
| Jul 31, 202610-Q | Quarterly report, Q2 2026 — revenue $3.87B (+23% y/y), net income $84.3M, EPS $0.38 |
| Jul 31, 20268-K | Earnings release — EPS $0.45 vs $0.37 est. (+21.6%); revenue $3.87B (+23% y/y) 18.1% |
| Jun 12, 20268-K | BrightSpring Health Services, Inc. Welcomes Dr. Nigam H. Shah to Board of DirectorsDirectors or officers; compensation; Regulation FD disclosure |
| Jun 5, 20268-K | Material definitive agreement |
| May 21, 20268-K | Shareholder vote results |
| May 1, 202610-Q | Quarterly report, Q1 2026 — revenue $3.61B (+26% y/y), net income $148.8M, EPS $0.67 |
| May 1, 20268-K | Earnings release — EPS $0.39 vs $0.29 est. (+34.5%); revenue $3.61B (+26% y/y) 9.6% |
| Apr 10, 2026ARS | Annual report to shareholders |
| Apr 10, 2026DEFA14A | Additional proxy materials |
| Apr 10, 2026DEF 14A | Proxy statement |
| Mar 31, 20268-K | BrightSpring Health Services Completes Sale of ResCare Community Living to SevitaCompletion of an acquisition or disposition; Directors or officers; compensation; Regulation FD disclosure |
| Mar 4, 20268-K | Material definitive agreement |
| Feb 27, 202610-K | Annual report, FY2025 — revenue $12.91B (+28% y/y), net income $190.7M, EPS $0.87 |
| Feb 27, 20268-K | Earnings release — EPS $0.33 vs $0.34 est. (−2.9%); revenue $3.55B (+29% y/y) 3.2% |
2025 · 21 filings
| Filed | What it is |
|---|---|
| Oct 28, 202510-Q | Quarterly report, Q3 2025 — revenue $3.33B (+28% y/y), net income $55.8M, EPS $0.26 |
| Oct 28, 20258-K | BrightSpring Health Services, Inc. Reports Third Quarter 2025 Financial Results and Increases Full Year 2025 GuidanceResults of operations |
| Oct 22, 20258-K | Material definitive agreement |
| Oct 20, 20258-K | Earnings release — EPS $0.30 vs $0.27 est. (+11.1%); revenue $3.33B (+28% y/y) 5.8% |
| Aug 1, 202510-Q | Quarterly report, Q2 2025 — revenue $3.15B (+29% y/y), net income $28.2M, EPS $0.13 |
| Aug 1, 20258-K | Earnings release — EPS $0.22 vs $0.19 est. (+15.8%); revenue $3.15B (+29% y/y) 4.9% |
| Jun 20, 20258-K | Directors or officers; compensation |
| Jun 12, 20258-K | Material definitive agreement |
| Jun 10, 20258-K | Other events |
| Jun 3, 20258-K | Shareholder vote results |
| May 5, 2025DEFA14A | Additional proxy materials |
| May 2, 202510-Q | Quarterly report, Q1 2025 — revenue $2.88B (+26% y/y), net income $29.5M, EPS $0.14 |
| May 2, 20258-K | Earnings release — EPS $0.19 vs $0.08 est. (+137.5%); revenue $2.88B (+26% y/y) 16.6% |
| Apr 18, 2025ARS | Annual report to shareholders |
| Apr 18, 2025DEFA14A | Additional proxy materials |
| Apr 18, 2025DEF 14A | Proxy statement |
| Apr 15, 20258-K/A | Directors or officers; compensation |
| Mar 6, 202510-K | Annual report, FY2024 — revenue $10.07B (+31% y/y), net income −$18.1M, EPS −$0.09 |
| Mar 6, 20258-K | Earnings release — EPS $0.22 vs $0.19 est. (+15.8%); revenue $2.75B (+122% y/y) 6.3% |
| Mar 5, 20258-K | Directors or officers; compensation; Regulation FD disclosure |
| Jan 21, 20258-K | Material definitive agreement; Regulation FD disclosure |
2024 · 17 filings
| Filed | What it is |
|---|---|
| Dec 11, 20248-K | Material definitive agreement; New financial obligation; Regulation FD disclosure |
| Nov 15, 20248-K | Directors or officers; compensation |
| Nov 1, 202410-Q | Quarterly report, Q3 2024 — revenue $2.60B (+15% y/y), net income −$8.2M, EPS −$0.04 |
| Nov 1, 20248-K | Earnings release — EPS $0.11 vs $0.18 est. (−38.9%); revenue $2.60B (+15% y/y) 15.2% |
| Oct 11, 20248-K | Directors or officers; compensation |
| Sep 30, 20248-K | Directors or officers; compensation; Regulation FD disclosure |
| Aug 2, 202410-Q | Quarterly report, Q2 2024 — revenue $2.44B (+13% y/y), net income $19.9M, EPS $0.10 |
| Aug 2, 20248-K | Earnings release — EPS $0.10 vs $0.18 est. (−44.4%); revenue $2.44B (+13% y/y) 8.7% |
| Jun 24, 20248-K | Unregistered sale of equity |
| May 31, 20248-K | Directors or officers; compensation |
| May 2, 202410-Q | Quarterly report, Q1 2024 — revenue $2.29B (+13% y/y), net income −$45.8M, EPS −$0.26 |
| May 2, 20248-K | Earnings release — EPS $0.12 vs $0.06 est. (+100.0%); revenue $2.29B (+13% y/y) 3.8% |
| Apr 26, 20248-K | Directors or officers; compensation |
| Mar 6, 202410-K | Annual report |
| Feb 29, 20248-K | Earnings release — EPS −$0.06 vs $0.15 est. (−140.0%) 7.6% |
| Feb 23, 20248-K | Material definitive agreement; New financial obligation |
| Jan 30, 20248-K | Material definitive agreement; Termination of a material agreement; Change to security holders' rights; Directors or officers; compensation; Charter, bylaws or fiscal-year change; Other events |
Insider, ownership and other filings#
Insider ownership (Forms 3, 4, 5 and 144), beneficial ownership (Schedules 13D and 13G), registration and prospectus (S-1, S-3, S-8, 424B and related) and the rest, counted by year, with the newest 25 of each of the latest 3 years shown. A Form 4 is one insider’s transaction report; a 13G is a passive holder above five percent.
2026 · 47 filings — 27 × 4, 8 × SCHEDULE 13G/A, 4 × 424B7 and 4 other forms
| Filed | What it is |
|---|---|
| Oct 30, 2026SCHEDULE 13G/A | Other filings |
| Oct 27, 20264 | Insider transaction (Form 4) |
| Sep 16, 20264 | Insider transaction (Form 4) |
| Sep 14, 2026144 | Notice of proposed sale (Form 144) |
| Aug 6, 2026SCHEDULE 13G/A | Other filings |
| Jul 31, 2026SCHEDULE 13G | Other filings |
| Jul 28, 20264 | Insider transaction (Form 4) |
| Jul 27, 2026SCHEDULE 13G/A | Other filings |
| Jun 22, 20264 | Insider transaction (Form 4) |
| Jun 12, 20264 | Insider transaction (Form 4) |
| Jun 12, 20263 | Initial insider holdings (Form 3) |
| Jun 5, 2026SCHEDULE 13D/A | Other filings |
| Jun 5, 20264 | Insider transaction (Form 4) |
| Jun 5, 20264 | Insider transaction (Form 4) |
| Jun 5, 20264 | Insider transaction (Form 4) |
| Jun 5, 20264 | Insider transaction (Form 4) |
| Jun 5, 20264 | Insider transaction (Form 4) |
| Jun 5, 2026424B7 | Registration and prospectus |
| Jun 3, 2026424B7 | Registration and prospectus |
| Jun 3, 2026144 | Notice of proposed sale (Form 144) |
| Jun 2, 2026144 | Notice of proposed sale (Form 144) |
| May 7, 20264 | Insider transaction (Form 4) |
| May 7, 20264 | Insider transaction (Form 4) |
| May 7, 20264 | Insider transaction (Form 4) |
| May 6, 2026SCHEDULE 13G/A | Other filings |
The newest 25 of 47 shown; the full year is on EDGAR.
2025 · 53 filings — 34 × 4, 4 × 424B7, 4 × SCHEDULE 13G/A and 6 other forms
| Filed | What it is |
|---|---|
| Nov 14, 2025SCHEDULE 13G | Other filings |
| Nov 12, 20254/A | Insider transaction (Form 4), amended |
| Nov 6, 20254 | Insider transaction (Form 4) |
| Oct 28, 20254 | Insider transaction (Form 4) |
| Oct 22, 20254 | Insider transaction (Form 4) |
| Oct 22, 20254 | Insider transaction (Form 4) |
| Oct 22, 2025SCHEDULE 13D/A | Other filings |
| Oct 22, 20254 | Insider transaction (Form 4) |
| Oct 22, 20254 | Insider transaction (Form 4) |
| Oct 21, 2025424B7 | Registration and prospectus |
| Oct 20, 2025424B7 | Registration and prospectus |
| Aug 14, 2025144 | Notice of proposed sale (Form 144) |
| Aug 7, 2025SCHEDULE 13G | Other filings |
| Jul 29, 20254 | Insider transaction (Form 4) |
| Jul 29, 20254 | Insider transaction (Form 4) |
| Jul 29, 2025SCHEDULE 13G | Other filings |
| Jun 27, 20253 | Initial insider holdings (Form 3) |
| Jun 26, 2025SCHEDULE 13D/A | Other filings |
| Jun 26, 20254 | Insider transaction (Form 4) |
| Jun 26, 20254 | Insider transaction (Form 4) |
| Jun 16, 20254 | Insider transaction (Form 4) |
| Jun 16, 20254 | Insider transaction (Form 4) |
| Jun 13, 20254 | Insider transaction (Form 4) |
| Jun 13, 20254 | Insider transaction (Form 4) |
| Jun 13, 20254 | Insider transaction (Form 4) |
The newest 25 of 53 shown; the full year is on EDGAR.
2024 · 67 filings — 25 × 4, 18 × 3, 5 × CORRESP and 13 other forms
| Filed | What it is |
|---|---|
| Nov 14, 2024SC 13G | Passive holder above 5% (Schedule 13G) |
| Nov 8, 20244 | Insider transaction (Form 4) |
| Nov 8, 20243 | Initial insider holdings (Form 3) |
| Nov 8, 2024SC 13G | Passive holder above 5% (Schedule 13G) |
| Oct 29, 20244 | Insider transaction (Form 4) |
| Oct 7, 2024SC 13G | Passive holder above 5% (Schedule 13G) |
| Sep 18, 2024SC 13D | Active holder above 5% (Schedule 13D) |
| Sep 16, 2024D | Other filings |
| Sep 13, 20244 | Insider transaction (Form 4) |
| Sep 13, 20244 | Insider transaction (Form 4) |
| Sep 13, 20244 | Insider transaction (Form 4) |
| Jul 26, 20244 | Insider transaction (Form 4) |
| May 21, 20244 | Insider transaction (Form 4) |
| May 13, 20244 | Insider transaction (Form 4) |
| May 7, 20244 | Insider transaction (Form 4) |
| May 7, 20244 | Insider transaction (Form 4) |
| Apr 30, 20243 | Initial insider holdings (Form 3) |
| Apr 26, 20244 | Insider transaction (Form 4) |
| Mar 18, 20244 | Insider transaction (Form 4) |
| Mar 18, 20244 | Insider transaction (Form 4) |
| Mar 18, 20244 | Insider transaction (Form 4) |
| Mar 18, 20244/A | Insider transaction (Form 4), amended |
| Mar 15, 20244 | Insider transaction (Form 4) |
| Mar 15, 20244 | Insider transaction (Form 4) |
| Mar 15, 20244 | Insider transaction (Form 4) |
The newest 25 of 67 shown; the full year is on EDGAR.
2023 · 9 filings — 3 × DRS/A, 3 × DRSLTR, 2 × UPLOAD and 1 other form
Counted, not listed; the year is on EDGAR.
2022 · 3 filings — 2 × S-1/A, 1 × RW
Counted, not listed; the year is on EDGAR.
2021 · 5 filings — 2 × DRS/A, 1 × DRS, 1 × S-1 and 1 other form
Counted, not listed; the year is on EDGAR.
About this data#
BrightSpring Health Services Inc. (BTSG) has 238 filings on EDGAR going back to 2021: 3 annual reports, 9 quarterly reports and 35 current reports, plus proxy statements, insider forms and ownership schedules. Its latest annual report, a 10-K, was filed on Feb 27, 2026 for the fiscal year ended Dec 31, 2025. The most recent 8-K, on Oct 30, 2026, furnished a press release headed “BrightSpring Health Services, Inc. Reports Third Quarter 2026 Financial Results and Increases Full Year 2026 Guidance”. Over the last 13 months insiders sold $3.36B in 11 sales and bought nothing on the open market; 48 other transactions (awards, exercises, tax withholding, gifts and plan purchases). Not investment advice.
Every row is a filing EDGAR lists for the registrants that have been BrightSpring Health Services Inc., read from the SEC’s submissions index each morning; a filing accepted after that read appears the next day. Where a company changed its filing entity (a holding-company reorganisation, Google into Alphabet) the predecessor’s filings are shown for the years it filed as the company, derived from the filings themselves. Dates are the filing date; the period is the report’s own. The latest 3 years of reports are listed in full, the next years to 10 without their 8-Ks, and older years are counted; the other forms are counted too, with the newest 25 of each of the latest 3 years shown. Insider transactions are the Form 4 and Form 5 documents themselves, filed since January 2026, every number as the insider filed it: a day’s lots are summed, a blank price adds its shares and no dollars, and a purchase through an employee stock plan is a plan purchase, not insider buying. An 8-K’s headline is the first line of the press release it furnishes (Exhibit 99), read from the filing and shown word for word; where two independent readings of the exhibit do not agree, the 8-K is described by its items instead. The documents stay on sec.gov, public domain, and every link opens the SEC’s copy. ChartRow does not summarise or interpret filings.
FAQ#
- Where can I read BTSG's latest 10-K?
- BTSG's latest annual report, a 10-K, was filed on Feb 27, 2026 for the fiscal year ended Dec 31, 2025. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.
- When did BTSG last file an 8-K?
- On Oct 30, 2026 it furnished a press release headed “BrightSpring Health Services, Inc. Reports Third Quarter 2026 Financial Results and Increases Full Year 2026 Guidance”. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Oct 30, 2026.
- Are BTSG insiders buying or selling?
- Over the last 13 months insiders sold $3.36B in 11 sales and bought nothing on the open market; 48 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: Greenwell Scott A. (President, PharMerica) sold 15,099 shares on Sep 14, 2026 for $874K, under a 10b5-1 plan. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.
- How many SEC filings has BTSG made?
- 238 filings are on EDGAR under the registrant records that have been BrightSpring Health Services Inc., going back to 2021; 113 of them are insider ownership forms (Forms 3, 4, 5 and 144).
